Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Completed × Interventional × L19-IL2 immunocytokine × Clear all

Phase

Status

Withdrawn 1 Terminated 1 Completed 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Other solid neoplasm 1

Conditions

Interventions

Cyclophosphamide 1320 Cisplatin 1241 Paclitaxel 1164 Radiotherapy 1138 Carboplatin 1095 Gemcitabine 1082 Docetaxel 990 Bevacizumab 925 Fluorouracil 796 Doxorubicin 703 Dexamethasone 663 Capecitabine 654 Rituximab 644 Oxaliplatin 623 Etoposide 600 Irinotecan 571 pembrolizumab 564 Filgrastim 552 Leucovorin 519 Cytarabine 517 Nivolumab 476 Vincristine 455 Prednisone 425 Bortezomib 412 Erlotinib Hydrochloride 411 Cetuximab 407 Trastuzumab 399 Methotrexate 379 Lenalidomide 368 Pemetrexed 365

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT02086721 2017-05-31

L19-IL2

Maastricht Radiation Oncology

Phase 1 Completed

Other solid neoplasm

Solid Tumour

Data powered by HemOnc (CC BY 4.0) Colophon ⚡